M. Basaras
University of the Basque Country
21 Papers
112 Citations
M. Basaras is an academic researcher from University of the Basque Country. The author has contributed to research in topics: Hepatitis B virus & Hepatitis C virus. The author has an hindex of 9, co-authored 21 publications.
Chat about Author
Papers
Phylogenetic analysis of GBV-C/hepatitis G virus.
B. Douglas Smith,M. Basaras,Simon D. W. Frost,Daniel T. Haydon,Narcisa Cuceanu,L E Prescott,Cara Kamenka,David N. Millband,Mahomed A. Sathar,Peter Simmonds +9 more
TL;DR: Comparison of 33 epidemiologically distinct GBV-C/hepatitis G virus complete genome sequences suggests the existence of four major phylogenetic groupings that are equally divergent from the chimpanzee isolate GBV(tro), suggesting that the long-term evolution of this RNA virus is extremely slow.
73
Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.
TL;DR: HPV E6/E7 mRNA detection may be an effective screening test and biomarker for cervical cancer in women infected with these five genotypes, Nonetheless, further studies are needed to standardize as routine triage test.
Seroprevalence of hepatitis B and C, and human immunodeficiency type 1 viruses in a rural population from the Republic of Equatorial Guinea.
TL;DR: The study demonstrates the existence of a high HBV carrier rate in children, concluding that hepatitis B vaccine should be incorporated into the Expanded Programme on Vaccination in Equatorial Guinea.
24
Late disappearance of hepatitis C virus RNA from peripheral blood mononuclear cells in patients with chronic hepatitis C in sustained response after α-interferon therapy
García-Bengoechea M,M. Basaras,Jesus Barrio,Elisabet Arrese,Inmaculada I. Montalvo,Juan Arenas,Ramón Cisterna +6 more
TL;DR: In the long-term follow-up, the majority of patients with chronic hepatitis C with sustained response after α-interferon therapy progressively lost HCV RNA from PBMCs.
14
Detection of hepatitis C virus RNA in serum and peripheral blood mononuclear cells in patients with chronic hepatitis C treated with interferon alpha.
TL;DR: It is confirmed that interferon therapy leads to inhibition of HCV replication but not eradication of the virus, and persists at extrahepatic sites may explain its reactivation after cessation of interferons.
14